首页> 外文期刊>Current Pharmaceutical Biotechnology >Enhancing Nucleic Acid Delivery, Insights from the Cationic Phospholipid Carriers
【24h】

Enhancing Nucleic Acid Delivery, Insights from the Cationic Phospholipid Carriers

机译:阳离子磷脂载体对提高核酸递送的启示

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The development of nucleic acid-based drugs has attracted considerable interest in the past two decades as a new category of biologics. A key challenge in successfully achieving the full potential of nucleotide therapeutics is their efficient delivery. Synthetic cationic lipids are currently the most extensively used non-viral nucleotide carriers because of their ability to form complexes with the nucleic acids. Here we examine the properties of oligonucleotide lipoplexes with a particularly noteworthy cationic lipid class, the cationic phosphatidylcholines (PCs) which exhibit low toxicity and good nucleotide delivery efficacy. Studies on a set of cationic PCs reveal the existence of a strong, systematic dependence of their carrier efficiency on the lipid hydrocarbon chain structure. Their activity rises with the increase in chain unsaturation and declines with the increase in chain length. Maximum transfection is detected for ethyl-PC (ePC) with monounsatu-rated 14:1 chains. The same lipid exhibits maximum activity also in intracellular delivery of siRNA. As the lipid phase behavior is known to depend substantially on the hydrocarbon chain structure, the above relationships validate a view that cationic PC phase properties are an important factor for their activity. Indeed, time-resolved X-ray diffraction studies showed that the rate of the nucleotide release from the lipoplexes, as well as their transfection activity, correlate with the non-lamellar phase progressions detected in mixtures of cationic PCs with biomembrane lipids. These findings emphasize the role of the non-lamellar lipid mesophases in the nucleic acid transport across the cellular membranes and their intracellular release.
机译:在过去的二十年中,基于核酸的药物作为一种新型的生物制剂引起了人们的极大兴趣。成功地发挥核苷酸治疗剂的全部潜力的关键挑战是它们的有效递送。合成阳离子脂质由于其与核酸形成复合物的能力,因此是目前使用最广泛的非病毒核苷酸载体。在这里,我们检查了具有特别值得注意的阳离子脂质类别的阳离子磷脂酰胆碱(PCs)的寡核苷酸脂复合物的特性,这些脂质表现出低毒性和良好的核苷酸传递功效。对一组阳离子PC的研究表明,它们的载流子效率对脂质烃链结构具有很强的系统依赖性。它们的活性随着链不饱和度的增加而增加,而随着链长度的增加而下降。检测到单链未饱和14:1链的乙基PC(ePC)的最大转染。同一脂质在siRNA的细胞内递送中也表现出最大的活性。由于已知脂质相的行为主要取决于烃链结构,因此上述关系证实了阳离子PC相性质是其活性的重要因素的观点。确实,时间分辨的X射线衍射研究表明,从脂质复合物中释放核苷酸的速率以及它们的转染活性与在阳离子PC与生物膜脂质的混合物中检测到的非层状相进展相关。这些发现强调了非层状脂质中间相在核酸跨细胞膜运输及其在细胞内释放中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号